Leerink Partnrs Issues Positive Outlook for ELDN Earnings
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Leerink Partnrs boosted their Q2 2025 EPS estimates for shares of Eledon Pharmaceuticals in a research note issued to investors on Wednesday, May 14th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings of ($0.26) per share for the quarter, […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Leerink Partnrs boosted their Q2 2025 EPS estimates for shares of Eledon Pharmaceuticals in a research note issued to investors on Wednesday, May 14th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings of ($0.26) per share for the quarter, […]
